PropertyValue
?:abstract
  • The incidence of extensively drug-resistant tuberculosis (XDR-TB) has been rising consistently in Pakistan, and the country is likely to experience another surge of cases in the midst of the COVID-19 crisis. It is imperative to consider how the rising proportion of XDR-TB is best tackled during the pandemic; this includes finding a solution to the problem of non-adherence at the level of community-based healthcare, the utility and practicality of simultaneous testing for COVID-19 and TB, and reconciliation of the World Health Organization’s recommendation of home-based treatment with the need for frequent monitoring of anti-tubercular therapy in XDR-TB. Operational research is needed expeditiously to bypass these limitations.
?:creator
?:doi
?:doi
  • 10.1017/dmp.2020.230
?:journal
  • Disaster_medicine_and_public_health_preparedness
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/ce50c205ea0af9e13016c71f0b91e23d85947ee6.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7371846.xml.json
?:pmcid
?:pmid
?:pmid
  • 32635960.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Extensively Drug-Resistant Tuberculosis in the Time of COVID-19—How has the Landscape Changed for Pakistan?
?:type
?:year
  • 2020-07-07

Metadata

Anon_0  
expand all